- Efficacy and safety of BORTEZOMIB treatment for refractory acute antibody-mediated rejection-a pilot study2018 | Ústřední knihovna
- De novo HLA Class II antibodies are associated with the development of chronic but not acute antibody-mediated rejection after liver transplantation - a retrospective study2020 | Přírodovědecká fakulta
- De novo HLA Class II antibodies are associated with the development of chronic but not acute antibody-mediated rejection after liver transplantation - a retrospective study2020 | Ústřední knihovna
- Plasmapheresis and intravenous immunoglobulin in the treatment and prevention of antibody mediated rejection2010 | Ústřední knihovna